Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

2,395 questions in 172 reviews · Gut

current versions
No studies 420 · 17.5%Ungraded 60 · 2.5%Very low 821 · 34.3%Low 602 · 25.1%Moderate 397 · 16.6%High 95 · 4%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Azathioprine or 6‐mercaptopurine vs placebo
Withdrawal due to adverse events · People with surgically‐induced remission in Crohn's disease
Azathioprine and 6‐mercaptopurine for maintenance of surgically‐induced remission in Crohn's disease (2019) · Cochrane
RR 0.9 [0.63, 1.29]3 studies · 408 participantsModerate
Azathioprine or 6‐mercaptopurine vs 5‐aminosalicylic acid
Clinical relapse · People with surgically‐induced remission in Crohn's disease
Azathioprine and 6‐mercaptopurine for maintenance of surgically‐induced remission in Crohn's disease (2019) · Cochrane
RR 1.05 [0.89, 1.24]4 studies · 347 participantsLow
Azathioprine or 6‐mercaptopurine vs 5‐aminosalicylic acid
Endoscopic relapse · People with surgically‐induced remission in Crohn's disease
Azathioprine and 6‐mercaptopurine for maintenance of surgically‐induced remission in Crohn's disease (2019) · Cochrane
RR 0.78 [0.52, 1.17]1 study · 35 participantsVery low
Any antibiotic regimen plus N‐acetylcysteine vs the same regimen without N‐acetylcysteine (with or without placebo)
Eradication rate · people withH pylori infection
N‐acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication (2019) · Cochrane
RR 0.74 [0.51, 1.08]8 studies · 559 participantsVery low
Any antibiotic regimen plus N‐acetylcysteine vs the same regimen without N‐acetylcysteine (with or without placebo)
Gastrointestinal adverse events · people withH pylori infection
N‐acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication (2019) · Cochrane
RR 1.25 [0.85, 1.85]5 studies · 336 participantsVery low
Any antibiotic regimen plus N‐acetylcysteine vs the same regimen without N‐acetylcysteine (with or without placebo)
Allergic adverse events · people withH pylori infection
N‐acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication (2019) · Cochrane
RR 2.98 [0.32, 27.74]5 studies · 336 participantsVery low
Any antibiotic regimen plus N‐acetylcysteine vs the same regimen without N‐acetylcysteine (with or without placebo)
Toxic adverse events · people withH pylori infection
N‐acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication (2019) · Cochrane
no estimate extracted5 studies · 336 participantsLow
Biofeedback plus standard therapy vs standard therapy
Clinical response (adequate improvement or remission) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
RR 4.2 [1.4, 12.58]1 study · 20 participantsVery low
Biofeedback plus standard therapy vs sham biofeedback plus standard therapy
Abdominal pain (Pain) Scale from: 0 to 4 Lower score = better · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted1 study · 20 participantsVery low
Biofeedback vs hypnotherapy
Clinical symptoms (Improvement) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted1 study · 61 participantsLow
Biofeedback vs hypnotherapy
Quality of life (QoL) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Biofeedback vs hypnotherapy
Adverse events (AE) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Biofeedback vs hypnotherapy
Serious adverse events (SAE) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Biofeedback vs hypnotherapy
Abdominal pain (Pain) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Biofeedback vs hypnotherapy
Depression · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted1 study · 61 participantsLow
Biofeedback vs hypnotherapy
Anxiety · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted1 study · 61 participantsLow
Biofeedback vs counseling
Composite Primary Symptom Reduction Score (CPSR) Scale from: ‐100 to 100 Higher score = better · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted1 study · 29 participantsLow
Biofeedback vs counseling
Clinical response · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
RR 1.09 [0.48, 2.45]1 study · 29 participantsLow
Biofeedback plus standard therapy vs standard therapy
Quality of life (QoL) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Biofeedback vs counseling
Quality of life (QoL) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted1 study · 29 participantsVery low
Biofeedback vs counseling
Adverse events (AE) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted1 study · 29 participantsLow
Biofeedback vs counseling
Serious adverse events (SAE) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted1 study · 29 participantsLow
Biofeedback vs counseling
Abdominal pain (Pain) Scale from: 0 to 4 Lower score = better · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted1 study · 29 participantsLow
Multi‐component psychological intervention (with biofeedback) vs no‐treatment control
Composite Primary Symptom Reduction Score (CPSR) Scale from: ‐100 to 100 higher score = better · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted3 studies · 101 participantsVery low
Multi‐component psychological intervention (with biofeedback) vs no‐treatment control
Clinical Response · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
RR 2.12 [1.24, 3.62]3 studies · 101 participantsVery low
Multi‐component psychological intervention (with biofeedback) vs no‐treatment control
Quality of life (QoL) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Multi‐component psychological intervention (with biofeedback) vs no‐treatment control
Adverse events (AE) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Multi‐component psychological intervention (with biofeedback) vs no‐treatment control
Serious adverse events (SAE) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Multi‐component psychological intervention (with biofeedback) vs no‐treatment control
Abdominal pain (Pain) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted2 studies · 82 participantsVery low
Biofeedback plus standard therapy vs standard therapy
Adverse events (AE) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Multi‐component psychological intervention (with biofeedback) vs no‐treatment control
Depression · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted2 studies · 82 participantsVery low
Multi‐component psychological intervention (with biofeedback) vs no‐treatment control
Anxiety (state) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted2 studies · 82 participantsVery low
Multi‐component psychological intervention (with biofeedback) vs no‐treatment control
Anxiety (trait) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted2 studies · 82 participantsVery low
Multi‐component psychological intervention (with biofeedback) vs attention control
Composite Primary Symptom Reduction Score (CPSR) Scale from: 0% to 100% Higher score = better · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted2 studies · 80 participantsVery low
Multi‐component psychological intervention (with biofeedback) vs attention control
Clinical response · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
RR 1.1 [0.72, 1.69]2 studies · 80 participantsVery low
Multi‐component psychological intervention (with biofeedback) vs attention control
Quality of life (QoL) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Multi‐component psychological intervention (with biofeedback) vs attention control
Adverse events (AE) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Multi‐component psychological intervention (with biofeedback) vs attention control
Serious adverse events (SAE) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Multi‐component psychological intervention (with biofeedback) vs attention control
Abdominal Pain (Pain) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted2 studies · 80 participantsVery low
Multi‐component psychological intervention (with biofeedback) vs attention control
Depression · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted2 studies · 80 participantsVery low
Biofeedback plus standard therapy vs standard therapy
Serious adverse events (SAE) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Multi‐component psychological intervention (with biofeedback) vs attention control
Anxiety (state) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted2 studies · 80 participantsVery low
Multi‐component psychological intervention (with biofeedback) vs attention control
Anxiety (trait) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted2 studies · 80 participantsVery low
Biofeedback vs relaxation training
Clinical improvement · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted1 study · 10 participantsVery low
Biofeedback vs relaxation training
Quality of life (QoL) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Biofeedback vs relaxation training
Adverse events (AE) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Biofeedback vs relaxation training
Serious adverse events (SAE) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extractedNRNo studies
Biofeedback vs relaxation training
Stool Frequency · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted1 study · 10 participantsVery low
Biofeedback vs relaxation training
Abdominal pain (Pain) · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted1 study · 10 participantsVery low
Biofeedback vs relaxation training
Depression · people with irritable bowel syndrome
Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane
no estimate extracted1 study · 10 participantsVery low